The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Abstract
Many tumour cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation. This persistence of high lactate production by tumours in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago. How tumour cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown. Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metabolism to aerobic glycolysis and that this promotes tumorigenesis. Tumour cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase. Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1. Switching pyruvate kinase expression to the M1 (adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate production and increased oxygen consumption, and this correlates with a reduced ability to form tumours in nude mouse xenografts. These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumour cells in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Paradoxically, decreased pyruvate kinase activity is associated with increased aerobic glycolysis, suggesting the activation of pyruvate kinase activity might be a way to target cancer (Christofk et al., 2008).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Christofk et al., 2008
In the citing paper
“Tumor cells engineered to exclusively express the M2 isoform display increased lactate production characteristic of the Warburg effect and gain a growth advantage in vivo over M1-expressing tumors (57).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [57]
In the citing paper
“PKM2 promotes the Warburg effect and tumorigenesis (Christofk et al., 2008; Hitosugi et al., 2009).”
From Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 (2011) · cites this paper as Christofk et al., 2008
In the citing paper
“Current data indicates that PKM2, when highly expressed, exists in an equilibrium of enzymatically inactive pyruvate kinase dimers (or monomers) which can translocate into the nucleus(Christofk et al., 2008; Hitosugi et al., 2009), and enzymatically active tetramers which are retained in the cytosol(Mazurek et al., 2005).”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Christofk et al., 2008
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Muller, W., Sinn, E., Pattengale, P., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,246
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
Self-citationMajumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 662
Growth factors can influence cell growth and survival through effects on glucose metabolism
Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5899-5912.2001 · Cited by 536
Self-citation
Cited by
Sorted by citations
Items 901–1,000 of 1,008
Stringari, C., Sierra, R., Donovan, P. J., & Gratton, E. (2012) · Journal of Biomedical Optics · doi:10.1117/1.jbo.17.4.046012 · Cited by 66
A Systems Biology Approach to Cancer: Fractals, Attractors, and Nonlinear Dynamics
Dinicola, S., D’Anselmi, F., Pasqualato, A., Proietti, S., Lisi, E., Cucina, A., & Bizzarri, M. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0091 · Cited by 66
JIANG, K., He, B., Lai, L., Chen, Q., Liu, Y., Guo, Q., & Wang, Q. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.989 · Cited by 66
Natural Compounds as Regulators of the Cancer Cell Metabolism
Cerella, C., Radogna, F., Dicato, M. A., & Diederich, M. F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/639401 · Cited by 67
Huang, S. K., Darfler, M. M., Nicholl, M. B., You, J., Bemis, K. G., Tegeler, T. J., Wang, M., Wery, J., Chong, K. K., Nguyen, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004430 · Cited by 66
Normal and cancer cell metabolism: lymphocytes and lymphoma
Altman, B. J., & Dang, C. V. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08651.x · Cited by 66
PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2
Li, N., Feng, L., Liu, H., Wang, J., Kasembeli, M. M., Tran, M. K., Tweardy, D. J., Lin, S. H., & Chen, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.070 · Cited by 66
Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm
Liu, Z., Le, Y., Chen, H., Zhu, J., & Lu, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.748573 · Cited by 66
The PHGDH enigma: Do cancer cells only need serine or also a redox modulator?
Li, A. M., & Ye, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.036 · Cited by 65
Lu, L., Wang, H., Liu, X., Tan, L., Qiao, X., Ni, J., Sun, Y., Liang, J., Hou, Y., & Dou, H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02279-9 · Cited by 65
Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis
Arundhathi, J. R. D., Mathur, S. R., Gogia, A., Deo, S. V. S., Mohapatra, P., & Prasad, C. P. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06414-w · Cited by 65
Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes
Apostolidi, M., Vathiotis, I. A., Muthusamy, V., Gaule, P., Gassaway, B. M., Rimm, D. L., & Rinehart, J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4190 · Cited by 65
The role of autophagy in neonatal tissues: Just a response to amino acid starvation?
Schiaffino, S., Mammucari, C., & Sandri, M. (2008) · Autophagy · doi:10.4161/auto.6143 · Cited by 65
The role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 65
Willers, I. M., & Cuezva, J. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.016 · Cited by 65
McDonnell, S. R. P., Hwang, S. R., Rolland, D. C. M., Murga‐Zamalloa, C., Basrur, V., Conlon, K. P., Fermin, D., Wolfe, T., Raskind, A. B., Ruan, C., et al. (2013) · Blood · doi:10.1182/blood-2013-01-482026 · Cited by 65
Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
Wang, Z., Jeon, H. Y., Rigo, F., Bennett, C. F., & Krainer, A. R. (2012) · Open Biology · doi:10.1098/rsob.120133 · Cited by 65
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
Barger, J. F., & Plas, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0106 · Cited by 65
Zhao, X., Zhao, L., Yang, H., Li, J., Min, X., Yang, F., Liu, J., & Huang, G. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000100 · Cited by 65
Chen, S., Youhong, T., Tan, Y., He, Y., Ban, Y., Cai, J., Li, X., Xiong, W., Zeng, Z., Li, G., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz180 · Cited by 64
Zhang, L., Ke, J., Min, S., Wu, N., Liu, F., Qu, Z., Li, W., Wang, H., Qian, Z., & Wang, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.691762 · Cited by 64
PKM2‐TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability
Liu, F., Ma, M., Gao, A., Ma, F., Ma, G., Liu, P., Jia, C., Wang, Y., Donahue, K., Zhang, S., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108065 · Cited by 64
Hofer, F., Sario, G. D., Musiu, C., Sartoris, S., Sanctis, F. D., & Ugel, S. (2021) · Cells · doi:10.3390/cells10102700 · Cited by 64
Jain, A., & Bhardwaj, V. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i39.6527 · Cited by 64
Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer
HAN, J., Meng, Q., Xi, Q., Zhang, Y., Zhuang, Q., Han, Y., Jiang, Y., Ding, Q., & Wu, G. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3225 · Cited by 64
Cui, H., Wu, F., Sun, Y., Fan, G., & Wang, Q. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-356 · Cited by 64
Peppicelli, S., Toti, A., Giannoni, E., Bianchini, F., Margheri, F., Rosso, M. D., & Calorini, L. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191706 · Cited by 64
Nonmetabolic functions of metabolic enzymes in cancer development
Lu, S., & Wang, Y. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0336-6 · Cited by 64
Jung, C. J., Iyengar, S., Blahnik, K. R., Ajuha, T. P., Jiang, J. X., Farnham, P., & Zern, M. Α. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027740 · Cited by 63
Liang, Y., Zhang, D., Zheng, T., Yang, G., Wang, J., Meng, F., Liu, Y., Zhang, G., Zhang, L., Han, J., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0242-z · Cited by 63
Zhang, C., Wang, H., Liu, Q., Dai, S., Tian, G., Wei, X., Li, X., Zhao, L., & Shan, B. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02827-6 · Cited by 63
RetractedGao, Z., & Cooper, T. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308806110 · Cited by 63
Martinez‐Balibrea, E., Plasencia, C., Ginés, A., Martínez‐Cardús, A., Musulén, E., Aguilera, R., Manzano, J. L., Neamati, N., & Abad, A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0882 · Cited by 63
New roles for pyruvate kinase M2: working out the Warburg effect
Ferguson, E. C., & Rathmell, J. C. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.05.006 · Cited by 63
Drivers of the Warburg Phenotype
Cairns, R. A. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000106 · Cited by 63
SRSF10 Regulates Alternative Splicing and Is Required for Adipocyte Differentiation
Li, H., Cheng, Y., Wu, W., Liu, Y., Wei, N., Feng, X., Xie, Z., & Feng, Y. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01674-13 · Cited by 63
Bhat, G. J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1113 · Cited by 63
Glucose-deprivation increases thyroid cancer cells sensitivity to metformin
Bikas, A., Jensen, K. E., Patel, A. D., Costello, J. M., McDaniel, D. P., Kłubo-Gwieździńska, J., Ларін, О. С., Hoperia, V., Burman, K. D., Boyle, L., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0402 · Cited by 63
Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
Zhao, J., Li, J., Fan, T. W. ‐., & Hou, X. S. (2017) · Oncotarget · doi:10.18632/oncotarget.18787 · Cited by 63
PKM2 in carcinogenesis and oncotherapy
He, X., Du, S., Lei, T., Li, X., Liu, Y., Wang, H., Tong, R., & Wang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22529 · Cited by 63
Chen, Z., Yu, Q., Hao, L., Liu, F., Johnson, J., Tian, Z., Kao, W. J., Xu, W., & Li, L. (2018) · The Analyst · doi:10.1039/c8an00216a · Cited by 63
Yang, J., Cao, Q., Zhang, H., Liang, H., Zhou, D., Gan, Z., Li, Z., Tong, Y., Ji, L., & Mao, Z. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.040 · Cited by 63
miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells
Lu, J., Wang, L., Chen, W., Wang, Y., Zhen, S., Chen, H., Cheng, J., Zhou, Y., Li, X., & Zhao, L. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.10.014 · Cited by 63
Warburg effect in Gynecologic cancers
Kobayashi, Y., Banno, K., Kunitomi, H., Takahashi, T., Takeda, T., Nakamura, K., Tsuji, K., Tominaga, E., & Aoki, D. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13867 · Cited by 63
Metabolic alterations in the tumor microenvironment and their role in oncogenesis
Eisenberg, L., Eisenberg‐Bord, M., Eisenberg‐Lerner, A., & Sagi‐Eisenberg, R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.016 · Cited by 63
O'Rourke, S. A., Neto, N. G. B., Devilly, E., Shanley, L. C., Fitzgerald, H. K., Monaghan, M. G., & Dunne, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.05.015 · Cited by 62
Glucose metabolic phenotype of pancreatic cancer
Chan, A. K. C., Bruce, J. I. E., & Siriwardena, A. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i12.3471 · Cited by 62
González‐Menéndez, P., Hevia, D., Rodríguez‐García, A., Mayo, J. C., & Sainz, R. M. (2014) · Endocrinology · doi:10.1210/en.2014-1260 · Cited by 62
Xu, Y., Wang, C., & Li, Z. (2013) · Molecular and Clinical Oncology · doi:10.3892/mco.2013.202 · Cited by 62
Geroncogenesis: Metabolic Changes during Aging as a Driver of Tumorigenesis
Wu, L. E., Gomes, A. P., & Sinclair, D. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.005 · Cited by 62
DeSouza, L. V., Krakovska, O., Darfler, M. M., Krizman, D. B., Romaschin, A. D., Colgan, T. J., & Siu, K. W. M. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201090103 · Cited by 62
Molecular Pathways: Tumor Cells Co-opt the Brain-Specific Metabolism Gene CPT1C to Promote Survival
Reilly, P. T., & Mak, T. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3281 · Cited by 62
Strmiska, V., Michálek, P., Eckschlager, T., Stiborová, M., Adam, V., Křížková, S., & Heger, Z. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.001 · Cited by 62
PKM2 regulates endothelial cell junction dynamics and angiogenesis via ATP production
Gómez-Escudero, J., Clemente, C., García-Weber, D., Acín‐Pérez, R., Millán, J., Enríquez, J. A., Bentley, K., Carmeliet, P., & Arroyo, A. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-50866-x · Cited by 62
Tumor metabolism regulating chemosensitivity in ovarian cancer
Han, C. Y., Patten, D. A., Richardson, R. B., Harper, M., & Tsang, B. K. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.176 · Cited by 62
Lin28A promotes IRF6-regulated aerobic glycolysis in glioma cells by stabilizing SNHG14
Lu, J., Liu, X., Zheng, J., Song, J., Liu, Y., Ruan, X., Shen, S., Shao, L., Yang, C., Wang, D., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2650-6 · Cited by 62
Metabolic alterations mediated by STAT3 promotes drug persistence in CML
Patel, S. B., Nemkov, T., Stefanoni, D., Benavides, G. A., Bassal, M. A., Crown, B. L., Matkins, V. R., Camacho, V., Kuznetsova, V., Hoang, A. T., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01315-0 · Cited by 56
New strategies for targeting glucose metabolism–mediated acidosis for colorectal cancer therapy
Wang, G., Wang, J., Yin, P., Xu, K., Wang, Y., Shi, F., Gao, J., & Fu, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26917 · Cited by 61
Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma
Sun, H., Zhu, A.-Y., Zhang, L., Zhang, J., Zhong, Z., & Wang, F. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024574 · Cited by 61
Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells
Rajagopalan, K. N., Egnatchik, R. A., Calvaruso, M. A., Wasti, A., Padanad, M. S., Boroughs, L. K., Ko, B., Hensley, C. T., Acar, M., Hu, Z., et al. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0134-4 · Cited by 61
Walsh, M. J., Brimacombe, K. R., Veith, H., Bougie, J. M., Daniel, T. O., Leister, W., Cantley, L. C., Israelsen, W. J., Heiden, M. G. V., Shen, M., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.114 · Cited by 61
Self-citationFrom cancer metabolism to new biomarkers and drug targets
Chiaradonna, F., Moresco, R. M., Airoldi, C., Gaglio, D., Palorini, R., Nicotra, F., Messa, C., & Alberghina, L. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.006 · Cited by 61
PKM2 and the Tricky Balance of Growth and Energy in Cancer
Macintyre, A. N., & Rathmell, J. C. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.003 · Cited by 61
Papadaki, C., Sfakianaki, M., Lagoudaki, E. D., Giagkas, G., Ioannidis, G., Trypaki, M., Tsakalaki, E., Voutsina, A., Koutsopoulos, A. V., Mavroudis, D., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.492 · Cited by 61
Ogawa, H., Nagano, H., Konno, M., Eguchi, H., Koseki, J., Kawamoto, K., Nishida, N., Colvin, H. S., Tomokuni, A., Tomimaru, Y., et al. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.490 · Cited by 61
Gao, F., Xia, Y., Wang, J., Lin, Z., Ou, Y., Liu, X., Liu, W., Zhou, B., Luo, H., Zhou, B., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0533-9 · Cited by 61
Kasvandik, S., Samuel, K., Peters, M., Eimre, M., Peet, N., Roost, A. M., Padrik, L., Paju, K., Peil, L., & Salumets, A. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00965 · Cited by 61
The Crabtree and Warburg effects: Do metabolite-induced regulations participate in their induction?
Hammad, N., Rosas‐Lemus, M., Uribe‐Carvajal, S., Rigoulet, M., & Devin, A. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.034 · Cited by 61
Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122537 · Cited by 61
Rizzieri, D., Paul, B. A., & Kang, Y. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.05 · Cited by 61
Reversible, functional amyloids: towards an understanding of their regulation in yeast and humans
Cereghetti, G., Saad, S., Dechant, R. C., & Peter, M. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1480220 · Cited by 61
Li, M., Lu, H., Wang, X., Duan, C., Zhu, X., Zhang, Y., Ge, X., Ji, F., Wang, X., Su, J., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.10.017 · Cited by 60
Zhu, Y., Shu, D., Gong, X., Lu, M., Feng, Q., Zeng, X.-B., Zhang, H., Gao, J., Guo, Y.-W., Liu, L., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18684 · Cited by 60
Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms
Taniguchi, K., Ito, Y., Sugito, N., Kumazaki, M., Shinohara, H., Yamada, N. O., Nakagawa, Y., Sugiyama, T., Futamura, M., Otsuki, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep08647 · Cited by 60
Exploiting the balance between life and death: Targeted cancer therapy and “oncogenic shock”
Sharma, S. V., & Settleman, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.001 · Cited by 60
Vitamin K3 and K5 are inhibitors of tumor pyruvate kinase M2
Chen, J., Jiang, Z., Wang, B., Wang, Y., & Hu, X. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.039 · Cited by 60
Availability, not respiratory capacity governs oxygen consumption of solid tumors
Vaupel, P. W., & Mayer, A. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.019 · Cited by 60
Peng, X., Gong, F., Zhao, Y., Zhou, L., Xie, Y., Liao, H.-L., Lin, H., Li, Z., Tang, M., & Tong, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027309 · Cited by 60
Venkatesan, A., Uzasci, L., Chen, Z., Rajbhandari, L., Anderson, C. F., Lee, M. H., Bianchet, M. A., Cotter, R. J., Song, H., & Nath, A. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-28 · Cited by 60
Shinohara, H., Taniguchi, K., Kumazaki, M., Yamada, N. O., Ito, Y., Otsuki, Y., Uno, B., Hayakawa, F., Minami, Y., Naoe, T., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.039 · Cited by 60
Christensen, D. R., Calder, P. C., & Houghton, F. D. (2015) · Scientific Reports · doi:10.1038/srep17500 · Cited by 60
Pyruvate kinase M2 regulates photoreceptor structure, function, and viability
Rajala, A., Wang, Y., Brush, R. S., Tsantilas, K. A., Jankowski, C. S. R., Lindsay, K. J., Linton, J. D., Hurley, J. B., Anderson, R. E., & Rajala, R. V. S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0296-4 · Cited by 60
siRNA in ovarian cancer – Delivery strategies and targets for therapy
van den Brand, D., Mertens, V., Massuger, L. F. A. G., & Brock, R. E. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.012 · Cited by 60
Hidden features: exploring the non-canonical functions of metabolic enzymes
Huangyang, P., & Simon, M. C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033365 · Cited by 60
The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer
Gionfra, F., Vito, P. D., Pallottini, V., Lin, H., Davis, P. J., Pedersen, J. Z., & Incerpi, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00532 · Cited by 60
Cytosolic PKM2 stabilizes mutant EGFR protein expression through regulating HSP90–EGFR association
Yang, Y., Cheng, T.-Y., Huang, S.-M., Su, C., Yang, P.-W., Lee, J.-M., Chen, C.-K., Hsiao, M., Hua, K.-T., & Kuo, M.-L. (2015) · Oncogene · doi:10.1038/onc.2015.397 · Cited by 60
Chang, H., Xu, Q., Li, J., Li, M. K., Zhang, Z., Ma, H., & Yang, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03990-4 · Cited by 59
Zheng, X., Ma, H., Wang, J., Huang, M., Fu, D., Qin, L., & Yin, Q. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101534 · Cited by 59
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
Cunha, A., Silva, P. M. A., Sarmento, B. F. C. C., & Queirós, O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112610 · Cited by 59
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Flores-Ponce, X., & Velasco, I. (2024) · Metabolomics · doi:10.1007/s11306-024-02181-4 · Cited by 59
Li, L., Huang, K., You, Y., Fu, X., Hu, L., Song, L., & Meng, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2368 · Cited by 59
Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine Phosphorylation
Bettaieb, A., Bakke, J., Nagata, N., Matsuo, K., Xi, Y., Liu, S., AbouBechara, D., Melhem, R., Stanhope, K. L., Cummings, B. P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441469 · Cited by 59
Self-citationCatabolic metabolism during cancer EMT
Cha, Y. H., Yook, J. I., Kim, H. S., & Kim, N. H. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0567-x · Cited by 59
Britton, D., Zen, Y., Quaglia, A., Selzer, S., Mitra, V., Lößner, C., Jung, S., Böhm, G., Schmid, P., Prefot, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090948 · Cited by 59
Filipp, F. V. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.115423 · Cited by 59
High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin
Wang, Z., Liu, D., Yin, B., Ju, W., Qiu, H., Xiao, Y., Chen, Y., Peng, X., & Lu, C.-M. (2017) · Oncotarget · doi:10.18632/oncotarget.15873 · Cited by 59
Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington’s disease
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0075 · Cited by 59
ME1 promotes basal-like breast cancer progression and associates with poor prognosis
Liao, R., Ren, G., Liu, H., Chen, X., Cao, Q., Wu, X., Li, J., & Dong, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-35106-y · Cited by 59
Structural and Functional Regulation of Lactate dehydrogenase-A in Cancer
Woodford, M. R., Chen, V. Z., Backe, S. J., Bratslavsky, G., & Mollapour, M. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0287 · Cited by 59
Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect
Kim, S., & Baek, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126173 · Cited by 59
Metadata
- Authors
- Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C.
- Affiliations
- Harvard University (US)
- Boston Children's Hospital (US)
- Broad Institute (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Cantley, Lewis C.
- ORCID
- Venue
- Nature
- Published
- 2008-03
- Volume
- 452
- Issue
- 7184
- Pages
- 230-233
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015207840
- Cited by
- 2,820
- References
- 20
- Citations by year
- 2026: 68 · 2025: 101 · 2024: 133 · 2023: 142 · 2022: 151 · 2021: 174 · 2020: 169 · 2019: 170 · 2018: 190 · 2017: 158 · 2016: 180 · 2015: 204 · 2014: 211 · 2013: 187 · 2012: 186
- FWCI
- 44.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (T32CA009172)
- National Institute of General Medical Sciences (R01GM056203)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- PKM2, alternative splicing, cancer metabolism, Warburg effect, aerobic glycolysis, carcinogenesis, phosphotyrosine binding, lactic acid production, oxygen consumption, glucose uptake, oxidative phosphorylation, tumor growth, glycolysis, tumor cell proliferation, tumor hypoxia
- MeSH terms
- Animals, Fructosediphosphates, Glycolysis, Humans, Lung Neoplasms, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Oxygen Consumption, Pyruvate Kinase, Gene Expression Regulation, Neoplastic, Alternative Splicing, Pyruvic Acid, Lactic Acid, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
